Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulthiame PK in Healthy Volunteers
NCT03400189Phase 1Completed
- Sponsor
- Lausanne University Hospital
- Start
- Feb 2018
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sultiame in epilepsy, sponsored by Lausanne University Hospital. Primary endpoints: Elimination half-life of sultiame at 9 weeks, Area Under Curve at 9 weeks and 2 more. Started Feb 2018; status: completed.
02
Drugs
sultiame
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03400189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400189.